Tag: doxorubicin

Thermosome Presents Encouraging Initial Clinical Data from Phase I Trial of Lead Compound THE001

— THE001 safe and well tolerated in first two dose level, demonstrating encouraging signs of clinical activity

— Data presented at The Connective Tissue Oncology Society (CTOS) Annual Meeting 2024

Thermosome, a drug development company focused on targeted tumor therapies, today announced encouraging initial clinical data from the ongoing Phase I study of its lead compound THE001 in patients with heavily pre-treated, locally advanced unresectable or metastatic soft tissue sarcoma (STS). The data were presented as a poster (#P410) titled “Phase I study of THE001 (DPPG₂-TSL-DOX) combined with regional hyperthermia in patients with locally advanced or metastatic soft tissue sarcoma” at The Connective Tissue Oncology Society (CTOS) Annual Meeting 2024 in San Diego, USA. Read more…